Table II.
T2N0 (n=105) | T3N0 (n=44) | |||||
---|---|---|---|---|---|---|
RT (n=94) | CRT (n=11) | P-value | RT (n=22) | CRT (n=22) | P-value | |
5-year OS | 66.9 | 90.9 | 0.147 | 18.2 | 72.4 | 0.001 |
5-year DSS | 89.8 | 100 | 0.302 | 49.5 | 85.7 | 0.018 |
5-year DFS | 54.9 | 90.9 | 0.046 | 13.6 | 54.5 | 0.001 |
5-year RFS | 74.8 | 100 | 0.085 | 43.6 | 66.2 | 0.039 |
Results are shown in % and significant p-values are shown in bold. RT, radiotherapy; CRT, chemoradiotherapy; OS, overall survival; DSS, disease-specific survival; DFS, disease-free survival; RFS, relapse-free survival.